Table 3.
HPV-16 molecular variants by anatomical subsite and sample origin
| HNSCC subsite | HPV-16 | AA/NA1 | E | Not typed | |
|---|---|---|---|---|---|
| (n) | n (%) | n (%) | n (%) | ||
| FCMSCSP | Total | 8 | 1 (12.5) | 5 (62.5) | 2 (25.0) |
| Oral cavity | 2 | 0 (0) | 2 (100.0) | 0 (0) | |
| Oropharynx | 0 | 0 (0) | 0 (0) | 0 (0) | |
| Larynx | 6 | 1 (16.7) | 3 (50.0) | 2 (33.3) | |
| ICESP | Total | 17 | 8 (47.1) | 7 (41.2) | 2 (11.7) |
| Oral cavity | 14 | 5 (35.7) | 7 (50.0) | 2 (14.3) | |
| Oropharynx | 3 | 3 (100.0) | 0 (0) | 0 (0) | |
| Larynx | 0 | 0 (0) | 0 (0) | 0 (0) |
FCMSCSP-Santa Casa de Sao Paulo, School of Medicine; ICESP-Cancer Institute of São Paulo. AA/NA1-Asian-American/North American, E-European